Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
World Kinase Inhibitors Market - Opportunities and Forecasts, 2021-2028
| A00086 | Pages: NA | May 2021 | 12700 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the World Kinase Inhibitors Market
Request Now !Protein kinase is an enzyme that shuffles protein structure by transferring phosphate collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety of cell functions such as cell cycle, cell differentiation, cell proliferation and apoptosis. These cell processes are used in regulating various cell activities in cancer. The global inhibitors market was valued at approximately $105 billion. Increase in incident of cancer diseases is driving the growth for kinase inhibitor market. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. This shows potential for kinase inhibitors in cancer therapies. The growth of kinase inhibitor market is hindered by cost of treatment and lack of funds in conducting research. For Example, the cost of TKI (Tyrosin kinase inhibitors) was approximately $26,400 in non-pharmaceutical spending in 2012
Increase in clinical trials for commercialization of kinase inhibitors in cancer treatment is facing challenges due to strict government regulations. However, an increase in investment from pharmaceutical companies is promoting the growth for kinase inhibitor market. This report provides an in depth analysis of clinical development and reimbursement strategies adopted by respective governments.Â
Key companies include in the report are Bristol-Myers Squibb, Boehringer Ingelheim, Cytrx Corporation, Eisai Inc. Eton Bioscience Inc., Glaxosmithkline, Merck Serono Sa, Novartis International Ag, Osi Pharmaceuticals Llc, Pfizer.
KEY BENEFITS
- The report provides key developmental strategies adopted by top market players engaged in this business so that companies involved in development kinase inhibitors market can get competitive intelligence of their competitors
- The report focuses on market estimation for types of kinase inhibitors and geographic segments are derived from current market scenario and expected market trends that are forecasted
- Competitive landscape and competitor strategy analysis would help in better planning and execution of business strategiesÂ
- SWOT analysis and strategic developments included in the report for key market players are included in the report to get better understanding of potential opportunities and challenges for companies
- Impact analysis of top 10 factors to provide market situation to top management of surgical equipment market.
KEY MARKET SEGMENTS
BY TYPES
- Tyrosin kinase inhibitors (TKI)
- Receptor Tyrosine Kinase Inhibitors
- EGFR
- PDGFR
- VEGFR
- HER2
- Non-Receptor Tyrosine Kinase Inhibitors
- BCR-ABL
- Janus Kinase (JAK) Inhibitor
- Mesenchymal Epithelial Transition Growth Factor (c-MET)
- Spleen Tyrosine Kinase (SYK) Inhibitors
- Mulikinase inhibitors
- Threonine kinase inhibitor
- mTOR Kinase Inhibitors
- B RAF
- RHO Kinase Inhibitors
- Cyclin Dependant Kinase Inhibitor
- Aurora Kinase Inhibitors
- MAP/MEK Kinase Inhibitors
- JNK Inhibitors
- Protein Kinase C Inhibitors
- PI3K Inhibitors
- Others (Monoclonal  antibody kinase inhibitor)
- Humanized monoclonal antibody
- Chimeric monoclonal antibody
- Human monoclonal antibody
BY GEOGRAPHYÂ
- North America
- Europe
- Asia-Pacific
- RoW
KEY AUDIENCES
- Pharmaceutical companies
- Private and Government research institutes
- Academic Institutes
- Healthcare facilities
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Kinase Inhibitors Market-
Opportunities and Forecasts, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers